Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Frontiers In Immunology

by Emma Fiallos, Paola Cociancic, José Guillermo Esteban, Carla Muñoz-Antoli, Rafael Toledo
April 21, 2026

Journal Of Crohn's And Colitis

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

by Torsten Kucharzik, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stuart Taylor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mariangela Allocca, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Johan Burisch, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pierre Ellul, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Marietta Iacucci, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Christian Maaser, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Pamela Baldin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Gauraang Bhatnagar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Shomron Ben-Horin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Dominik Bettenworth, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mallory Chavannes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Ann Driessen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Emma Flanagan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Frederica Furfaro, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Giovanni Maconi, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstaninos Karmiris, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Amelia Kellar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Isabelle De Kock, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Konstantinos Katsanos, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Uri Kopylov, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Cathy Lu, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Olga Maria Nardone, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nurulamin M Noor, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Kerri Novak, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Paula Borralho Nunes, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Patrick van Rheenen, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jordi Rimola, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Francesca Rosini, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), David Rubin, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Martina Scharitzer, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Jaap Stoker, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Mathieu Uzzan, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Stephan Vavricka, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Bram Verstockt, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Rune Wilkens, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Nina Zidar, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Alessandra Zilli, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Henit Yanai, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO), Roger Feakins, the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS) on behalf of the European Crohn’s and Colitis Organisation (ECCO)
July 31, 2025

Journal Of Crohn's And Colitis

Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures

Journal Of Crohn's And Colitis

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Original Source(s)

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Related Content

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host–Microbiome–Metabolomic Signatures

ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries